Published in BMC Nephrol on February 26, 2014
A systematic review of the predictors of disease progression in patients with autosomal dominant polycystic kidney disease. BMC Nephrol (2015) 0.84
Screening for Unruptured Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease: A Survey of 420 Nephrologists. PLoS One (2016) 0.78
The impact of comorbidity on survival after hemorrhagic stroke among dialysis patients: a nationwide population-based study. BMC Nephrol (2014) 0.78
Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol (2009) 9.40
Subarachnoid haemorrhage. Lancet (2007) 7.10
Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol (2010) 5.79
Intracranial aneurysms. N Engl J Med (1997) 5.73
Autosomal dominant polycystic kidney disease. N Engl J Med (1993) 5.64
Cerebral aneurysms. N Engl J Med (2006) 4.88
Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke (2003) 3.56
The risk of subarachnoid and intracerebral hemorrhages in blacks as compared with whites. N Engl J Med (1992) 3.56
Validation of comorbid conditions on the end-stage renal disease medical evidence report: the CHOICE study. Choices for Healthy Outcomes in Caring for ESRD. J Am Soc Nephrol (2000) 3.27
Intracranial aneurysms in autosomal dominant polycystic kidney disease. N Engl J Med (1992) 2.34
The incidence of deep and lobar intracerebral hemorrhage in whites, blacks, and Hispanics. Neurology (2005) 2.32
Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol (2010) 2.31
Estimating prevalence in single-gene kidney diseases progressing to renal failure. Kidney Int (2000) 2.20
The burden, trends, and demographics of mortality from subarachnoid hemorrhage. Neurology (1998) 2.08
Polycystic kidney disease re-evaluated: a population-based study. Q J Med (1991) 2.05
Causes of death in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1995) 1.81
Racial variations in location and risk of intracerebral hemorrhage. Stroke (2005) 1.78
Occult intracranial aneurysms in polycystic kidney disease: screening with MR angiography. Radiology (1994) 1.70
Risk factors for incident stroke among patients with end-stage renal disease. J Am Soc Nephrol (2003) 1.57
Rupture of a previously documented small asymptomatic intracranial aneurysm in a patient with autosomal dominant polycystic kidney disease. Case report. J Neurosurg (1998) 1.41
Vascular expression of polycystin-2. J Am Soc Nephrol (2001) 1.28
Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2. J Am Soc Nephrol (1996) 1.24
Epidemiology and genetics of intracranial aneurysms. Eur J Radiol (2013) 1.21
Screening for intracranial aneurysm in 355 patients with autosomal-dominant polycystic kidney disease. Stroke (2010) 1.10
Saccular intracranial aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1992) 1.09
Update on subarachnoid haemorrhage. J Neurol (2008) 1.08
Prevalence of cardiovascular events in patients with autosomal dominant polycystic kidney disease. Am J Nephrol (2012) 1.06
Outcome of renal replacement therapy in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant (1996) 1.01
Value of magnetic resonance angiography for the detection of intracranial aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1993) 0.99
Intracranial aneurysms in autosomal dominant polycystic kidney disease. Kidney Int (1994) 0.94
Incidence of hemorrhagic stroke in black Caribbean, black African, and white populations: the South London stroke register, 1995-2004. Stroke (2007) 0.94
Diagnosis of autosomal-dominant polycystic kidney disease: an integrated approach. Semin Nephrol (2010) 0.93
Subdural hematomas in chronic dialysis patients: significant and increasing. Clin J Am Soc Nephrol (2007) 0.93
Familial clustering of ruptured intracranial aneurysms in autosomal dominant polycystic kidney disease. Am J Kidney Dis (2001) 0.89
Molecular pathogenesis of subarachnoid haemorrhage. Int J Biochem Cell Biol (2003) 0.88
Intracranial aneurysms and dolichoectasia in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant (2002) 0.85
The genetics of vascular complications in autosomal dominant polycystic kidney disease (ADPKD). Curr Hypertens Rev (2013) 0.84
Factors associated with lobar vs. non-lobar intracerebral hemorrhage. Acta Neurol Scand (2011) 0.80
Simultaneous hemorrhage in intracranial aneurysms and in renal cyst in a case of polycystic kidney disease. Saudi J Kidney Dis Transpl (2012) 0.76
'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis (2012) 5.70
Excerpts from the US Renal Data System 2009 Annual Data Report. Am J Kidney Dis (2010) 3.11
US Renal Data System 2010 Annual Data Report. Am J Kidney Dis (2011) 2.90
Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States. Am J Kidney Dis (2005) 2.81
US Renal Data System 2013 Annual Data Report. Am J Kidney Dis (2014) 2.68
US Renal Data System 2012 Annual Data Report. Am J Kidney Dis (2013) 2.54
Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK). J Am Soc Nephrol (2003) 2.21
Excerpts from the United States Renal Data System 2006 Annual Data Report. Am J Kidney Dis (2007) 2.16
United States Renal Data System 2008 Annual Data Report. Am J Kidney Dis (2009) 2.14
Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol (2005) 2.07
Excerpts from the United States Renal Data System 2007 annual data report. Am J Kidney Dis (2008) 2.01
Cost-utility analysis of sodium polystyrene sulfonate vs. potential alternatives for chronic hyperkalemia. Clin Nephrol (2014) 1.98
Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease. J Am Soc Nephrol (2011) 1.90
Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol (2003) 1.84
Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United States. Am J Kidney Dis (2003) 1.70
Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation (2005) 1.62
Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study. J Am Soc Nephrol (2003) 1.56
Successful blood pressure control in the African American Study of Kidney Disease and Hypertension. Arch Intern Med (2002) 1.43
Damned if you do, damned if you don't: potassium binding resins in hyperkalemia. Clin J Am Soc Nephrol (2010) 1.35
Thrombotic microangiopathy after renal transplantation in the United States. Am J Kidney Dis (2003) 1.34
Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation. Transplantation (2008) 1.27
Association of incident gout and mortality in dialysis patients. J Am Soc Nephrol (2008) 1.20
Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial. Am J Kidney Dis (2009) 1.17
Metabolic syndrome, proteinuria, and the risk of progressive CKD in hypertensive African Americans. Am J Kidney Dis (2008) 1.15
Racial disparities in renal replacement therapy. J Natl Med Assoc (2002) 1.15
Parathyroidectomy versus cinacalcet hydrochloride-based medical therapy in the management of hyperparathyroidism in ESRD: a cost utility analysis. Am J Kidney Dis (2007) 1.14
Incidence of sodium polystyrene sulfonate-associated colonic necrosis. Am J Med (2013) 1.11
New agents for hyperkalemia. N Engl J Med (2015) 1.09
Factors associated with improved short term survival in obese end stage renal disease patients. Ann Epidemiol (2003) 1.09
Association of prescription of oral sodium polystyrene sulfonate with sorbitol in an inpatient setting with colonic necrosis: a retrospective cohort study. Am J Kidney Dis (2012) 1.08
The role of anemia management in improving outcomes for African-Americans with chronic kidney disease. Am J Nephrol (2008) 1.04
Association of serum albumin and atherosclerosis in chronic hemodialysis patients. Am J Kidney Dis (2002) 1.03
The transcriptional activity of osterix requires the recruitment of Sp1 to the osteocalcin proximal promoter. Bone (2011) 1.02
Transjugular renal biopsy in high-risk patients: an American case series. BMC Nephrol (2002) 0.97
Early renal insufficiency and hospitalized heart disease after renal transplantation in the era of modern immunosuppression. J Am Soc Nephrol (2003) 0.97
Racial disparities in kidney health: the puzzle to solve. Am J Kidney Dis (2002) 0.95
Cardiovascular risk assessment among potential kidney transplant candidates: approaches and controversies. Am J Kidney Dis (2009) 0.94
Global approaches for understanding the disproportionate burden of chronic kidney disease. Ethn Dis (2009) 0.93
Incidence, predictors and associated outcomes of renal cell carcinoma in long-term dialysis patients. Urology (2011) 0.93
ACE inhibition is effective and renoprotective in hypertensive nephrosclerosis: the African American Study of Kidney Disease and Hypertension (AASK) trial. Kidney Int Suppl (2003) 0.91
Thrombotic microangiopathy in United States long-term dialysis patients. Nephrol Dial Transplant (2005) 0.90
Poor outcomes associated with neutropenia after kidney transplantation: analysis of United States Renal Data System. Transplantation (2011) 0.90
Induction of an osteocyte-like phenotype by fibroblast growth factor-2. Biochem Biophys Res Commun (2010) 0.87
Treatment of secondary hyperparathyroidism with parathyroidectomy instead of cinacalcet: time to pick the low-hanging fruit? Am J Kidney Dis (2012) 0.86
Use of beta-blockers and aspirin after myocardial infarction by patient renal function in the Department of Defense health care system. Am J Kidney Dis (2006) 0.86
Racial differences and income disparities are associated with poor outcomes in kidney transplant recipients with lupus nephritis. Transplantation (2013) 0.85
Milestones for nephrology training programs: a modest proposal. Am J Kidney Dis (2013) 0.84
Acute coronary syndromes after renal transplantation in patients with end-stage renal disease resulting from diabetes. Am J Transplant (2002) 0.83
Relation between asymptomatic proteinase 3 antibodies and future granulomatosis with polyangiitis. Clin J Am Soc Nephrol (2013) 0.82
Hypertensive chronic kidney disease in African Americans: strategies for improving care. Cleve Clin J Med (2012) 0.82
International use of an academic nephrology World Wide Web site: from medical information resource to business tool. Mil Med (2002) 0.82
A multidisciplinary program for achieving lipid goals in chronic hemodialysis patients. BMC Nephrol (2002) 0.80
The prevalence of BK polyomavirus infection in outpatient kidney transplant recipients followed in a single center. Clin Transplant (2008) 0.80
Kidney disease in disadvantaged populations. Int J Nephrol (2012) 0.79
An unusual cause of acute kidney injury due to oxalate nephropathy in systemic scleroderma. Clin Nephrol (2015) 0.79
Cardiorenal metabolic syndrome in the African diaspora: rationale for including chronic kidney disease in the metabolic syndrome definition. Ethn Dis (2009) 0.78
Effects of Traumatic Amputation on β-Trace Protein and β2-Microglobulin Concentrations in Male Soldiers. Am J Nephrol (2016) 0.77
Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome after renal transplantation in the United States. BMC Endocr Disord (2003) 0.77
Ethnic disparities in the prevalence and treatment of kidney disease. Nephrol News Issues (2004) 0.77
Poor outcomes in elderly kidney transplant recipients receiving alemtuzumab induction. Am J Nephrol (2011) 0.77
Impact of Poverty and Health Care Insurance on Arteriovenous Fistula Use among Incident Hemodialysis Patients. Am J Nephrol (2015) 0.76
Effect of intensive blood pressure control on cardiovascular remodeling in hypertensive patients with nephrosclerosis. Int J Nephrol (2013) 0.76
Biopsy: observation time after kidney biopsy: when to discharge? Nat Rev Nephrol (2009) 0.76
Dipsogenic diabetes insipidus: report of a novel treatment strategy and literature review. Clin Exp Nephrol (2006) 0.76
Preservation of renal structure and function at 2 years without calcineurin inhibitor use. Am J Transplant (2005) 0.75
Initiating and completing the kidney transplant evaluation process: the Red Queen's race. Clin J Am Soc Nephrol (2012) 0.75
Hypertension as an emerging risk factor for acute heart failure in Africa: comment on "The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries". Arch Intern Med (2012) 0.75
The next GME accreditation system. N Engl J Med (2012) 0.75
Making the crooked way straight: interpreting geography and health care delivery in CKD. Clin J Am Soc Nephrol (2013) 0.75
Exploring new treatments for chronic kidney disease. Kidney Int (2012) 0.75
Combating Grade Inflation in Nephrology Clinical Rotation Evaluations Using Faculty Education and a 5-Point Centered Rating Scale. J Grad Med Educ (2016) 0.75
Reply to the letter. Clin Nephrol (2015) 0.75
Non-Adherence Codes in the New ICD-10: Need for Prospective Trials. Am J Nephrol (2015) 0.75
Nothing to sneeze at: efficacy and cost-effectiveness of the influenza vaccine in patients receiving long-term dialysis. Am J Kidney Dis (2011) 0.75
On improving outcomes and quality of dialysis care, and more. Am J Kidney Dis (2002) 0.75
Kidney disease in disadvantaged populations: An unconquered challenge. Clin Nephrol (2016) 0.75
Differing manifestations of hepatitis C and tacrolimus on hospitalized diabetes mellitus occurring after kidney transplantation. Ann Epidemiol (2005) 0.75
A 20-year-old army private with leg pain, fever, and collapse during a forced road march. Mil Med (2002) 0.75
Successful CAVH in an austere environment using readily available disposable hospital supplies. Nephrol Dial Transplant (2007) 0.75
Cost-effectiveness of antiplatelet therapy to prolong primary patency of hemodialysis graft. Clin Nephrol (2014) 0.75
Therapeutic plasma exchange as a nephrological procedure: a single-center experience. J Clin Apher (2005) 0.75
Impact of isometric handgrip exercises on cephalic vein diameter in non-AVF candidates, a pilot study. J Vasc Access (2012) 0.75
Mortality after Renal Allograft Failure and Return to Dialysis. Am J Nephrol (2017) 0.75